Covered recipient · General Payments record
ALAN M NADOUR
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$8,990.13
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $307.10 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | $135.96 | 1 |
| Novo Nordisk AS | $57.58 | 3 |
| Nevro Corp. | $53.09 | 3 |
| ORGANOGENESIS INC. | $21.59 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.19 | 1 |
| Lilly USA, LLC | $17.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Becton, Dickinson and Company | $135.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127634641 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.19 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117964565 | CMS |
| Lilly USA, LLC | $17.69 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136011489 | CMS |
| Nevro Corp. | $16.01 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130783156 | CMS |
| Nevro Corp. | $18.41 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130783212 | CMS |
| Nevro Corp. | $18.67 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130783154 | CMS |
| Novo Nordisk Inc | $21.40 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096690995 | CMS |
| Novo Nordisk Inc | $14.09 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097052574 | CMS |
| Novo Nordisk Inc | $22.09 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096932607 | CMS |
| Organogenesis Inc. | $21.59 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145440371 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.